A guideline for the clinical management of basal cell naevus syndrome (Gorlin-Goltz syndrome)

B J A Verkouteren^{1

2}, B Cosgun^{1

2}, M G H C Reinders^{1

2}, P A W K Kessler³, R J Vermeulen⁴, M Klaassens⁵, S Lambrechts⁶, J R van Rheenen⁷, M van Geel^{1

2

8}, M Vreeburg⁸, K Mosterd^{1

2}

Affiliations

¹ Department of Dermatology, Maastricht University Medical Centre, Maastricht, the Netherlands.
² GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.
³ Department of Cranio-Maxillofacial Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands.
⁴ Department of Neurology, Maastricht University Medical Centre, Maastricht, the Netherlands.
⁵ Department of Paediatrics, Maastricht University Medical Centre, Maastricht, the Netherlands.
⁶ Department of Gynaecology, Maastricht University Medical Centre, Maastricht, the Netherlands.
⁷ Department of Ophthalmology, St. Anna Hospital, Geldrop, the Netherlands.
⁸ Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, the Netherlands.

Practice Guideline

B J A Verkouteren et al. Br J Dermatol. 2022 Feb.

. 2022 Feb;186(2):215-226.

doi: 10.1111/bjd.20700. Epub 2021 Nov 8.

¹ Department of Dermatology, Maastricht University Medical Centre, Maastricht, the Netherlands.
² GROW Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.
³ Department of Cranio-Maxillofacial Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands.
⁴ Department of Neurology, Maastricht University Medical Centre, Maastricht, the Netherlands.
⁵ Department of Paediatrics, Maastricht University Medical Centre, Maastricht, the Netherlands.
⁶ Department of Gynaecology, Maastricht University Medical Centre, Maastricht, the Netherlands.
⁷ Department of Ophthalmology, St. Anna Hospital, Geldrop, the Netherlands.
⁸ Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, the Netherlands.

Abstract

Linked Comment: E. Epstein. Br J Dermatol 2022; 186:203.

Plain language summary available online

How to manage patients with Gorlin syndrome.
Epstein E Jr. Epstein E Jr. Br J Dermatol. 2022 Feb;186(2):203. doi: 10.1111/bjd.20839. Epub 2021 Nov 22. Br J Dermatol. 2022. PMID: 34806167 No abstract available.

1. Peris K, Fargnoli MC, Garbe C et al. Diagnosis and treatment of basal cell carcinoma: European consensus‐based interdisciplinary guidelines. Eur J Cancer 2019; 118:10–34. - PubMed
1. Work G, Invited R, Kim JYS et al. Guidelines of care for the management of basal cell carcinoma. J Am Acad Dermatol 2018; 78:540–59. - PubMed
1. Orphanet . Expert center: Gorlin syndrome. Available at https://www.orpha.net/consor/cgi‐bin/OC_Exp.php?Lng=GB&Expert=377 (last accessed 8 September 2021).
1. Brouwers MC, Kho ME, Browman GP et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010; 182:E839–42. - PMC - PubMed
1. Evans DG, Howard E, Giblin C et al. Birth incidence and prevalence of tumor‐prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 2010; 152A:327–32. - PubMed